SARAH WHITE

Sarah White, MPH, has served as Executive Director of the MRCT Center since 2018, leading strategy, operations, and financial stewardship to advance the Center’s mission and expand its impact across the clinical research community. With more than 25 years of experience across large academic medical centers and industry, Sarah is a recognized leader in human subjects’ research.  Sarah leads the Center’s efforts in post-trial responsibilities and co-leads the Center’s global efforts to modernize regulatory and ethics committee systems, with a particular focus on scalable solutions in low- and middle-income countries. An expert in ICH GCP E6(R3) Good Clinical Practice, she leads the development of the official ICH E6(R3) training course, shaping capacity building and implementation of international standards in clinical research. Sarah brings a public health and quality improvement lens to her leadership, prioritizing the usability, impact, and adoption of the Center’s outputs across diverse stakeholders. 

Prior to joining the MRCT Center, Sarah served as Director of the Human Research Quality Improvement Program (QI Program) at Partners’ Healthcare (now Mass General Brigham) in Boston, where she led system-wide strategy and operations to enhance the quality and compliance of human research across multiple institutions, including Massachusetts General Hospital and Brigham and Women’s Hospital. She also directed FDA Sponsor-Investigator regulatory support and the centralized support of clinical trials registration and disclosure functions.  Sarah is Co-Chair of the national Clinical Trials Registration Taskforce, a large consortium of academic medical centers, hospitals and universities that advances best practices and policy alignment for clinical trial transparency across US academic institutions.  Sarah holds an undergraduate degree from Dartmouth College and an MPH from the Boston University School of Public Health.